BRIEF-Biogen says in July 2017 learned that prosecution office of Milan is investigating interactions with some healthcare providers in Italy - SEC Filing
* Biogen says in July 2017 learned that prosecution office of Milan is investigating interactions with some healthcare providers in Italy - SEC Filing
NEW YORK, July 25 U.S. prosecutors questioned their last witness in the securities fraud trial of Martin Shkreli on Tuesday, while the former drug company executive's lawyers said they do not expect to call any witnesses of their own, setting the stage for closing arguments later this week.
* Medical Facilities Corporation appoints Robert O. Horrar as chief operating officer Source text for Eikon: Further company coverage:
BRIEF-Crispr Therapeutics intellia therapeutics, Caribou Biosciences, ERS Genomics announce Appellate Brief seeking reversal of patent decision on Crispr/Cas9 gene editing
* Crispr Therapeutics, Intellia Therapeutics, Caribou Biosciences, ERS Genomics announce appellate brief seeking reversal of patent decision on crispr/cas9 gene editing
WASHINGTON, July 25 U.S. Senate Republicans narrowly agreed on Tuesday to open debate on a bill to end Obamacare, but the party's seven-year effort to roll back Democratic President Barack Obama's signature healthcare law still faces significant hurdles.
No related earnings announcements are currently scheduled within the next 7 days.